HS

Helen Jane Szekeres

Merck: 5 patents #2,116 of 9,382Top 25%
EL Eli Lilly: 4 patents #824 of 2,858Top 30%
MD Merk Sharp & Dohme: 1 patents #1 of 28Top 4%
📍 Bisley, GB: #1 of 8 inventorsTop 15%
Overall (All Time): #483,756 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
12344584 KCNQ potentiators Maria Ann Whatton, Andrew Caerwyn Williams 2025-07-01
11840516 KCNQ potentiators Maria Ann Whatton, Andrew Caerwyn Williams 2023-12-12
11208383 KCNQ potentiators Maria Ann Whatton, Andrew Caerwyn Williams 2021-12-28
8049013 5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5H-thiazolo[5,4-C] pyridin-4-one derivatives and their use as MCH receptor antagonists Kevin Matthew Gardinier, David Joseph Garmene, Erik James Hembre, Michael Brunavs 2011-11-01
7271191 Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of Alzheimer's disease Michela Bettati, Mark Stuart Chambers, Peter Hunt, Philip Jones, Angus Murray MacLeod +1 more 2007-09-18
7153868 N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists Mark Stuart Chambers, Philip Jones 2006-12-26
7094777 5-HT2A receptor ligands Mark Stuart Chambers, Neil Roy Curtis, Angus Murray MacLeod, Robert Maxey 2006-08-22
6936608 Imidazo-triazine derivatives as ligands for GABA receptors Michela Bettati, Peter Blurton, William R. Carling, Mark Stuart Chambers, David Hallett +5 more 2005-08-30
6900209 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition Mark Stuart Chambers, Philip Jones, Angus Murray MacLeod, Robert Maxey 2005-05-31
6900215 Imidazo-pyrimidine derivatives as ligands for gaba receptors Mark Stuart Chambers, Simon Charles Goodacre, David Hallett, Andrew Jennings, Philip Jones +4 more 2005-05-31